Press release
Gastrointestinal Stromal Tumors Market is trending with CAGR of 7% by 2023, Key Players- Bayer AG, Novartis AG, Immunicum AB, F. Hoffmann-La Roche Ltd, and AB SCIENCES
Global Gastrointestinal Stromal Tumors Market - Overview
One of the most common form of sarcoma is gastrointestinal stromal tumors (GIST) involving the gastrointestinal tract. Gastrointestinal stromal tumors can occur anyplace within the GI tract but is most often found in the stomach i.e. about in 40-70% of the cases and 20-30% in the small intestine. Every year approximately 11 to 20 million people worldwide are diagnosed with GIST.
The gastrointestinal stromal tumors market is expected to grow at a steady pace. The factors influencing the growth of the market include increasing prevalence of gastrointestinal diseases, increasing prevalence of cancer, increasing investments and funding in the field of life science research, increasing awareness among the people, growing geriatric population, changing reimbursement policies and various others.
Request Sample with New Market Trends @ https://www.marketresearchfuture.com/sample_request/1583
The market is forecasted to demonstrate a same growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period 2017 – 2022.
Global Gastrointestinal Stromal Tumors Market - Competitive Analysis
Characterized by the presence of several well-established and small players, the global market of gastrointestinal stromal tumors appears to be highly competitive and fragmented.
There has been increasing development in the field of Gastrointestinal Stromal Tumors. Companies are keen in developing new products for the same. In November 2016, announced supplemental New Drug Application (sNDA) for Stivarga tablets had been submitted for the approval to the U.S. Food and Drug Administration (FDA) for the second-line systemic treatment of patients with unresectable hepatocellular carcinoma (uHCC).
Hepatocellular carcinoma (HCC), is the most common form of liver cancer accounting for more than 70-85 percent of liver cancer across the world. Stivarga is already been approved for the treatment of patients with metastatic gastrointestinal stromal tumor (GIST), metastatic colorectal cancer (mCRC).
Obtain Report Details with TOC @ https://www.marketresearchfuture.com/reports/gastrointestinal-stromal-tumors-market-1583
Adding to this in June 2017, Bayer announced that the Committee for Medicinal Products for Human Use (CHMP) the European Medicines Agency recommended regorafenib (oral multi-kinase inhibitor) for the treatment of grownup patients with hepatocellular carcinoma (HCC) who have been previously treated with Nexavar.
Regorafenib is the only treatment method that has been demonstrated a major improvement in overall survival in second-line hepatocellular carcinoma HCC patients who formerly had no other options for the treatment. The approval of European Commission on the commercial authorization is expected by the end of 2018.
Global Gastrointestinal Stromal Tumors Market - Regional Analysis
Global gastrointestinal stromal tumors market is segmented on the basis of geographies or regions which mainly includes North America, Europe, Asia Pacific, and Middle East & Africa. North America is dominating the global market for gastrointestinal stromal tumors with more than 35% share of the total market in 2016. The major factor for the growth of the market include due to increasing prevalence of liver cancer.
According to Centers for Disease Control and Preventation, every year in the U.S. about 22,000 men & 9,000 women get liver cancer, and more than 16,000 men & 8,000 women die from the same disease.
Europe holds the second largest share of the global gastrointestinal stromal tumors market. Asia Pacific is the fastest growing gastrointestinal stromal tumors stimulation market across the globe.
The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
Get Excusive Discount @ https://www.marketresearchfuture.com/check-discount/1583
Major Points form TOC for Gastrointestinal Stromal Tumors Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Cancer Immunotherapy Market, By Type
Chapter 7. Global Cancer Immunotherapy Market, By Treatment
Chapter 8 Global Cancer Immunotherapy Market, By End User
Chapter 9. Global Cancer Immunotherapy Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastrointestinal Stromal Tumors Market is trending with CAGR of 7% by 2023, Key Players- Bayer AG, Novartis AG, Immunicum AB, F. Hoffmann-La Roche Ltd, and AB SCIENCES here
News-ID: 1186598 • Views: …
More Releases from Market Research Future
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Chapter
New Chapter-by-Chapter Column to Spotlight Local Authors Across the Sandhills
SANFORD, N.C. - September 2025 - Sandhills.News is launching Chapter-by-Chapter, a new column dedicated to celebrating writers from Moore, Lee, and Harnett counties. The series will highlight books, authors, and storytelling that reflect the culture and creativity of the Sandhills region.
"This column is a way for neighbors to discover the writers in their own backyards," said Stephanie Sellers, editor of Sandhills.News. "It's about strengthening connections through literature and offering…
Austin Bankruptcy Lawyers Guide Clients Through Chapter 7 & Chapter 13 Filings
Austin Bankruptcy Lawyers helps individuals and families in Texas overcome debt through Chapter 7 and Chapter 13 filings. The firm's bankruptcy attorney in Texas offers personalized legal support, clear guidance, and long-term financial solutions.
Austin, TX - For many individuals and families in Austin, TX, who face overwhelming debt, bankruptcy provides a pathway to a fresh start. Austin Bankruptcy Lawyers provides comprehensive legal services for Chapter 7 and Chapter 13 filings.…
New Jersey Bankruptcy Attorney Daniel Straffi Clarifies Key Differences Between …
New Jersey bankruptcy attorney Daniel Straffi (https://www.straffilaw.com/what-is-the-difference-between-new-jersey-bankruptcy-chapter-7-and-chapter-13/), of Straffi & Straffi Attorneys at Law, sheds light on the critical distinctions between Chapter 7 and Chapter 13 bankruptcy for individuals and small businesses facing financial challenges. When unexpected circumstances such as job loss, illness, or divorce lead to overwhelming debt, understanding these two legal pathways can provide much-needed relief. Daniel Straffi explains how each option offers tailored solutions to help debtors…
Chapter 13 Lawyer Daniel Straffi Unveils Comprehensive Guide on Understanding Ch …
Chapter 13 lawyer [https://www.straffilaw.com/new-jersey-chapter-13-lawyer/] Daniel Straffi of Straffi & Straffi Attorneys at Law has recently published a detailed article enlightening individuals on the intricacies of Chapter 13 bankruptcy in New Jersey. This guide serves as an essential resource, offering clarity and direction for those grappling with significant debt and seeking financial rehabilitation.
The article by the Chapter 13 lawyer provides an in-depth look at the "wage earner's plan," which is tailored…
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand
The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Robert Wolf as the new Chapter President of AFEA’s Orange, CA Chapter.
With the addition of Robert Wolf as the new Chapter President, AFEA is expanding…
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand
The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Angelica Jones as the new Chapter President of AFEA’s Glendale, California Chapter.
With the addition of Angelica Jones as the new Chapter President, AFEA is expanding…
